|
| | SCOR Advisory Committee | | | | The scientific advisory board provides for scientific quality control, direction and interchange. Members of the scientific advisory board visit MUSC for a full day to meet with SCOR investigators and advise on programmatic and scientific issues. During these visits, the monthly SCOR meetings are used as a time for feedback and informal interactions between advisory board members and the MUSC SCOR team. Particular attention is given to areas of overlap and potential collaborations not yet realized. Board members also advise on issues concerning administration, outreach, and educational activities related to the SCOR. Finally, they meet with the SCOR Co-Directors in closed session to provide feedback. Advisory board members are often invited for Grand Rounds and/or the Addiction Seminar series. These visits will be organized as described above with both individual consultation, a group meeting with the SCOR team, and individual meetings with the Co-PI’s. The advisory board members bring a unique blend of skills, expertise and perspective which help to strengthen the interdisciplinary and translational science and solidify the cohesion of the SCOR research team.
| | Shelley Greenfield, M.D., Harvard University, Department of Psychiatry | | | Dorothy Hatsukami, Ph.D., University of Minnesota, Department of Psychiatry | | Peter Kalivas, Ph.D., Medical University of South Carolina, Department of Neurosciences | | Edward D. Levin, Ph.D., Duke University, Department of Psychiatry and Behavioral Sciences | | Carrie Randall, Ph.D., Medical University of South Carolina, Department of Psychiatry | | | Jane Stewart, Ph.D., Concordia University, Department of Psychology | | | | | | | | | |
|
| |
